Supplementary Figure 2 from Circulating Inflammation Biomarkers and the Risk of Esophageal Adenocarcinoma: A Nested Case–Control Study in the Department of Defense Serum Repository

Supplementary Figure 2. Associations of esophageal adenocarcinoma per quantile increase in circulating novel biomarkers in the Department of Defense Serum Repository. Odd Ratios (ORs) adjusted for matching variables, education, marital status, and biomarkers associated with increasing body mass index (EN-RAGE, FGF21, VEGFR3). (A) displays ORs for the biomarkers in the Inflammation Panel, (B) displays ORs for the biomarkers in the Oncology II Panel, and (C) displays ORs for the biomarkers in the Cardiovascular III Panel.